Accessibility Menu
MediPharm Labs logo

MediPharm Labs

(OTC) MEDIF

Current Price$0.05
Market Cap$21.77M
Since IPO (2018)-97%
5 Year-87%
1 Year-2%
1 Month-15%

MediPharm Labs Financials at a Glance

Market Cap

$21.77M

Revenue (TTM)

CA$43.30M

Net Income (TTM)

-CA$8.75M

EPS (TTM)

-$0.02

P/E Ratio

-3.39

Dividend

$0.00

Beta (Volatility)

0.63 (Low)

Price

$0.05

Volume

16,500

Open

$0.05

Previous Close

$0.05

Daily Range

$0.05 - $0.05

52-Week Range

$0.04 - $0.08

Estimated Earnings Date

Aug 14, 2024

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MediPharm Labs

Industry

Pharmaceuticals

Employees

127

CEO

Greg Hunter, MBA, CPA

Headquarters

Barrie, ON L4N 2L1, CA

MEDIF Financials

Key Financial Metrics (TTM)

Gross Margin

30.63%

Operating Margin

-20.37%

Net Income Margin

-20.21%

Return on Equity

-23.55%

Return on Capital

-24.00%

Return on Assets

-20.05%

Earnings Yield

-29.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$21.77M

Shares Outstanding

424.86M

Volume

16.50K

Avg. Volume

80.19K

Financials (TTM)

Gross Profit

CA$13.13M

Operating Income

-CA$8.70M

EBITDA

-CA$6.98M

Operating Cash Flow

-CA$3.23M

Capital Expenditure

-CA$59.00K

Free Cash Flow

-CA$3.29M

Cash & ST Invst.

CA$9.89M

Total Debt

CA$18.05K

MediPharm Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$8.99M

-16.8%

Gross Profit

CA$3.48M

-16.8%

Gross Margin

38.71%

N/A

Market Cap

$21.77M

N/A

Market Cap/Employee

$131.14K

N/A

Employees

166

N/A

Net Income

-CA$869.24K

-124.6%

EBITDA

-CA$467.20K

-965.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$9.89M

+14.7%

Total Debt

CA$18.05K

-85.6%

Accounts Receivable

CA$6.55M

-15.9%

Inventory

CA$8.49M

-19.8%

Long Term Debt

CA$0.00

-100.0%

Short Term Debt

CA$36.05K

-61.7%

Return on Assets

-20.05%

N/A

Return on Invested Capital

-25.12%

N/A

Free Cash Flow

-CA$781.01K

+74.4%

Operating Cash Flow

-CA$780.01K

+74.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RVXCFResverlogix Corp.
$0.07-9.81%
RAPHRaphael Pharmaceutical Inc.
$1.40+0.00%
AVCNFAvicanna Inc.
$0.09-3.95%
GBLPGlobal Pharmatech, Inc.
$0.08+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.57+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.63+0.02%
BBBlackBerry
$11.03+0.07%
SDOTSadot Group
$19.06+2.08%

Questions About MEDIF

What is the current price of MediPharm Labs?

MediPharm Labs is trading at $0.05 per share.

What is the 52-week range for MediPharm Labs?

Over the past 52 weeks, MediPharm Labs has traded between $0.04 and $0.08.

How much debt does MediPharm Labs have?

As of the most recent reporting period, MediPharm Labs reported total debt of CA$12.90K.

How much cash does MediPharm Labs have on hand?

MediPharm Labs reported CA$7.07M in cash and cash equivalents in its most recent financial results.

What is MediPharm Labs’s dividend yield?

MediPharm Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.